Total Hip Arthroplasty Complications in Patients With Sickle Cell Disease: A Comparison Study

Background: Total hip arthroplasty (THA) is one of the most common orthopaedic procedures performed in the United States, but there are rare complications which can be devastating. Sickle cell disease (SCD) can lead to avascular necrosis of the femoral head, often necessitating THA. This article see...

Full description

Saved in:
Bibliographic Details
Main Authors: Christian DeMaio, BS, Conner Patrick, MD, Grayson Domingue, MD, Jake Fox, MD, Justin Dvorak, PhD, Rishi Thakral, MD
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Arthroplasty Today
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352344124001973
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850249161231826944
author Christian DeMaio, BS
Conner Patrick, MD
Grayson Domingue, MD
Jake Fox, MD
Justin Dvorak, PhD
Rishi Thakral, MD
author_facet Christian DeMaio, BS
Conner Patrick, MD
Grayson Domingue, MD
Jake Fox, MD
Justin Dvorak, PhD
Rishi Thakral, MD
author_sort Christian DeMaio, BS
collection DOAJ
description Background: Total hip arthroplasty (THA) is one of the most common orthopaedic procedures performed in the United States, but there are rare complications which can be devastating. Sickle cell disease (SCD) can lead to avascular necrosis of the femoral head, often necessitating THA. This article seeks to better characterize the complication risks in patients undergoing THA with SCD when compared to osteoarthritis (OA) using a large database from the National Inpatient Sample. Methods: National Inpatient Sample data from 2006 through the third quarter of 2015 were analyzed using International Classification of Diseases, Ninth Revision codes. A weighted frequency of 4,350,961 THAs were recorded for OA and 4279 for SCD. These were compared using a Rao-Scott chi-squared test, and the prespecified complications were given sampling weights to approximate national estimates. Results: The following complications were found to occur at a significantly increased frequency in patients with OA with SCD vs OA only: wound infection (0.69% vs 0.36%), dislocation (1.68% vs 0.80%), and urinary complications (3.61% vs 2.35%). SCD, when evaluated independent of avascular necrosis, was reported with higher frequency wound infection (0.86% vs 0.36%), and overall complications (7.25% vs 5.06%). Additionally, multiple comorbidities were significantly more prevalent in the SCD population compared to OA patients. Conclusions: This study illustrates that patients with SCD have increased complication rates when compared to OA patients. This information benefits orthopaedic surgeons in preoperative and postoperative planning and counseling patients for realistic expectations. Furthermore, this study provides data that could benefit decision-making on bundled reimbursement for this specific patient population.
format Article
id doaj-art-11e828682b1b4fb6b141ddf4bae3864d
institution OA Journals
issn 2352-3441
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series Arthroplasty Today
spelling doaj-art-11e828682b1b4fb6b141ddf4bae3864d2025-08-20T01:58:33ZengElsevierArthroplasty Today2352-34412024-12-013010151210.1016/j.artd.2024.101512Total Hip Arthroplasty Complications in Patients With Sickle Cell Disease: A Comparison StudyChristian DeMaio, BS0Conner Patrick, MD1Grayson Domingue, MD2Jake Fox, MD3Justin Dvorak, PhD4Rishi Thakral, MD5University of Oklahoma College of Medicine, Oklahoma City, OK, USA; Corresponding author. Department of Orthopedic Surgery and Rehabilitation, University of Oklahoma Health Sciences Center, 800 Stanton L Young Blvd, Andrews Academic Tower 3400, Oklahoma City, OK 73104, USA. Tel.: +1 405 271 4426.Department of Orthopedic Surgery and Rehabilitation, University of Oklahoma Health Sciences Center, klahoma City, OK, USADepartment of Orthopedic Surgery and Rehabilitation, University of Oklahoma Health Sciences Center, klahoma City, OK, USADepartment of Orthopaedic Surgery, Vanderbilt University Medical Center, Nashville, TN, USAUniversity of Oklahoma College of Public Health, Oklahoma City, OK, USADepartment of Orthopedic Surgery and Rehabilitation, University of Oklahoma Health Sciences Center, klahoma City, OK, USABackground: Total hip arthroplasty (THA) is one of the most common orthopaedic procedures performed in the United States, but there are rare complications which can be devastating. Sickle cell disease (SCD) can lead to avascular necrosis of the femoral head, often necessitating THA. This article seeks to better characterize the complication risks in patients undergoing THA with SCD when compared to osteoarthritis (OA) using a large database from the National Inpatient Sample. Methods: National Inpatient Sample data from 2006 through the third quarter of 2015 were analyzed using International Classification of Diseases, Ninth Revision codes. A weighted frequency of 4,350,961 THAs were recorded for OA and 4279 for SCD. These were compared using a Rao-Scott chi-squared test, and the prespecified complications were given sampling weights to approximate national estimates. Results: The following complications were found to occur at a significantly increased frequency in patients with OA with SCD vs OA only: wound infection (0.69% vs 0.36%), dislocation (1.68% vs 0.80%), and urinary complications (3.61% vs 2.35%). SCD, when evaluated independent of avascular necrosis, was reported with higher frequency wound infection (0.86% vs 0.36%), and overall complications (7.25% vs 5.06%). Additionally, multiple comorbidities were significantly more prevalent in the SCD population compared to OA patients. Conclusions: This study illustrates that patients with SCD have increased complication rates when compared to OA patients. This information benefits orthopaedic surgeons in preoperative and postoperative planning and counseling patients for realistic expectations. Furthermore, this study provides data that could benefit decision-making on bundled reimbursement for this specific patient population.http://www.sciencedirect.com/science/article/pii/S2352344124001973Hip arthroplastyOsteoarthritisSickle cell diseasePerioperative morbidityOutcomes
spellingShingle Christian DeMaio, BS
Conner Patrick, MD
Grayson Domingue, MD
Jake Fox, MD
Justin Dvorak, PhD
Rishi Thakral, MD
Total Hip Arthroplasty Complications in Patients With Sickle Cell Disease: A Comparison Study
Arthroplasty Today
Hip arthroplasty
Osteoarthritis
Sickle cell disease
Perioperative morbidity
Outcomes
title Total Hip Arthroplasty Complications in Patients With Sickle Cell Disease: A Comparison Study
title_full Total Hip Arthroplasty Complications in Patients With Sickle Cell Disease: A Comparison Study
title_fullStr Total Hip Arthroplasty Complications in Patients With Sickle Cell Disease: A Comparison Study
title_full_unstemmed Total Hip Arthroplasty Complications in Patients With Sickle Cell Disease: A Comparison Study
title_short Total Hip Arthroplasty Complications in Patients With Sickle Cell Disease: A Comparison Study
title_sort total hip arthroplasty complications in patients with sickle cell disease a comparison study
topic Hip arthroplasty
Osteoarthritis
Sickle cell disease
Perioperative morbidity
Outcomes
url http://www.sciencedirect.com/science/article/pii/S2352344124001973
work_keys_str_mv AT christiandemaiobs totalhiparthroplastycomplicationsinpatientswithsicklecelldiseaseacomparisonstudy
AT connerpatrickmd totalhiparthroplastycomplicationsinpatientswithsicklecelldiseaseacomparisonstudy
AT graysondominguemd totalhiparthroplastycomplicationsinpatientswithsicklecelldiseaseacomparisonstudy
AT jakefoxmd totalhiparthroplastycomplicationsinpatientswithsicklecelldiseaseacomparisonstudy
AT justindvorakphd totalhiparthroplastycomplicationsinpatientswithsicklecelldiseaseacomparisonstudy
AT rishithakralmd totalhiparthroplastycomplicationsinpatientswithsicklecelldiseaseacomparisonstudy